BDI (Blood Diagnostics, Inc.) Announces Continued Growth Through Q2

COLUMBIA, SC–(EMWNews – July 17, 2008) – BDI, a national leader in the distribution of

biopharmaceutical products, announced that sales for the first two quarters

of 2008 continued to demonstrate an increase of more than twenty percent

(20%) in comparison to same time period in 2007. With a history of strong

third and fourth quarter sales, BDI projects that year end revenues, which

have grown at an average rate of twenty-three percent (23%) per year from

2004 – 2007, will meet or surpass expectations for the current fiscal year.

“The variables which affect the dynamics of the market sector we serve are

unique,” said William Shirey, Executive Vice-President of BDI. “Our

continued growth accurately illustrates the capabilities of BDI to respond

to customer and trade partner demands in a timely and efficient manner

providing value unparalleled at the wholesale distributor level.”

About BDI

Serving the healthcare community since 1995, Blood Diagnostics, Inc. (BDI),

the preeminent national wholesaler of specialty biopharmaceutical products,

has built an outstanding reputation as an industry source for products and

service. BDI’s market focus is evident in its commitment to specialty

biotherapeutics, immunologics and hemostatics, including Albumin (Human)

USP, intravenous immune globulin (IVIG or IGIV), coagulation factors VIII,

IX, and VIIa, as well as hyper-immunes, injectables and physician specialty

pharmaceuticals. As a recognized Authorized Distributor of Record for the

products it supplies from distribution centers located on both the East and

West coast, BDI services the entire country and is fully accredited and

insured, fulfilling the licensing requirements in all 50 states.

In an arena where access to pertinent clinical data and updated information

on market availability is paramount to patient care, BDI defines its

customer-centric approach to serving the nation’s healthcare community

through innovative inventory management programs, unparalleled customer

service, extensive product knowledge, unique promotional services,

emergency availability and urgent need delivery. The company serves as a

free source for reference material and market data, offering healthcare

providers the latest information on products, supply and other industry

events. BDI’s educational literature and web site — www.ivig.com — serve

as open-access resources, contributing to the promotion of the

biopharmaceutical industry and the education of both the healthcare

community and general populace.